Neuropace, Inc. Common Stock

NPCENASDAQUSD
14.60 USD
0.05 (0.34%)AT CLOSE (11:59 AM EDT)
14.62
0.00 (0.00%)
POST MARKET (AS OF 04:14 PM EDT)
Post Market
AS OF 04:14 PM EDT
14.62
0.00 (0.00%)
🟢Market: OPEN
Open?$14.62
High?$14.98
Low?$14.26
Prev. Close?$14.65
Volume?162.7K
Avg. Volume?226.9K
VWAP?$14.58
Rel. Volume?0.72x
Bid / Ask
Bid?$14.60 × 100
Ask?$14.64 × 100
Spread?$0.04
Midpoint?$14.62
Valuation & Ratios
Market Cap?493.2M
Shares Out?33.7M
Float?21.6M
Float %?65.4%
P/E Ratio?N/A
P/B Ratio?25.92
EPS?-$0.64
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?5.28Strong
Quick Ratio?4.33Strong
Cash Ratio?1.22Strong
Debt/Equity?3.09High
ValuationFAIRLY VALUED
Score
67/100
P/E?
N/A
P/B?
25.92HIGH
P/S?
4.93FAIR
P/FCF?
N/A
EV/EBITDA?
-32.9CHEAP
EV/Sales?
5.30FAIR
Returns & Efficiency
ROE?
-112.8%WEAK
ROA?
-20.3%WEAK
Cash Flow & Enterprise
FCF?$-11338000
Enterprise Value?$530.4M
Related Companies
Loading...
News
Profile
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
Employees
209
Market Cap
493.2M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2021-04-22
Address
455 N. BERNARDO AVENUE
MOUNTAIN VIEW, CA 94043
Phone: (650) 237-2700